Discovery Barred In Patent Re-Exams, Fed. Circ. Rules
The Federal Circuit ruled Wednesday that discovery is not allowed in inter partes patent re-examinations, rejecting a bid by Johnson & Johnson's Cordis Corp. unit to subpoena rival Abbott Laboratories as...To view the full article, register now.
Already a subscriber? Click here to view full article